Reductions in locomotor activity following central opioid receptor subtype antagonists in rats

[1]  S. Cooper,et al.  Drug receptor subtypes and ingestive behaviour , 1996 .

[2]  M. Kluger,et al.  Body temperature, motor activity, and feeding behavior of mice treated with β-chlornaltrexamine , 1995, Physiology & Behavior.

[3]  M. Meyer,et al.  Intra-accumbens δ 1-opioid agonist, pCl-DPDPE, differentially affects patterns of locomotor activity , 1995, Pharmacology Biochemistry and Behavior.

[4]  M. E. Meyer,et al.  DALDA (H-Tyr-D-Arg-Phe-Lys-NH2), a potent μ-opioid peptide agonist, affects various patterns of locomotor activities , 1995, Pharmacology Biochemistry and Behavior.

[5]  G. Pasternak,et al.  Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats , 1995, Brain Research.

[6]  R. Spanagel,et al.  Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. , 1994, European journal of pharmacology.

[7]  M. Meyer,et al.  Biphasic effects of intraaccumbens μ-opioid peptide agonist DAMGO on locomotor activities , 1994, Pharmacology Biochemistry and Behavior.

[8]  C. Paronis,et al.  Naltrexone in vivo protects μ receptors from inactivation by β-funaltrexamine, but not κ receptors from inactivation by nor-binaltorphimine , 1993, Pharmacology Biochemistry and Behavior.

[9]  W. Bowen,et al.  Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. , 1993, European journal of pharmacology.

[10]  M. Meyer,et al.  Behavioral effects of the μ-opioid peptide agonists DAMGO, DALDA, and PL017 on locomotor activities , 1993, Pharmacology Biochemistry and Behavior.

[11]  M. E. Meyer,et al.  Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities , 1993, Pharmacology Biochemistry and Behavior.

[12]  J. B. Justice,et al.  Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens , 1992, Pharmacology Biochemistry and Behavior.

[13]  Declan Jones,et al.  Long term κ-opioid receptor blockade following nor-binaltorphimine , 1992 .

[14]  H. Yamamura,et al.  Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. , 1992, The Journal of pharmacology and experimental therapeutics.

[15]  W. Bowen,et al.  Ingestive behavior following central [D-Ala2, Leu5, Cys6]-Enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor , 1991, Pharmacology Biochemistry and Behavior.

[16]  G. Pasternak,et al.  Reduction by central ß-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions , 1990, Brain Research.

[17]  R. Bodnar,et al.  Suppression of nocturnal, palatable and glucoprivic intake in rats by the κ opioid antagonist, nor-binaltorphamine , 1990, Brain Research.

[18]  J. Costentin,et al.  MU and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice , 1989, Neuropeptides.

[19]  M. Ukai,et al.  Effects of β-funaltrexamine on ingestive behaviors in the rat , 1988 .

[20]  G. Pasternak,et al.  Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintainance of body weight in rats , 1988, Neuropharmacology.

[21]  S. Holtzman,et al.  Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats , 1987, Neuropharmacology.

[22]  N. Swerdlow,et al.  Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: Evidence for a pre-synaptic locus , 1987, Pharmacology Biochemistry and Behavior.

[23]  P. Schnur,et al.  Naloxone reversal of morphine elicited hyperactivity. , 1987, Life sciences.

[24]  J. Morley,et al.  Opioids and consummatory behavior , 1985, Brain Research Bulletin.

[25]  R. Bodnar,et al.  Involvement of opioid receptor subtypes in rat feeding behavior. , 1985, Life sciences.

[26]  J. Morley,et al.  Opioid modulation of appetite , 1983, Neuroscience & Biobehavioral Reviews.

[27]  H. Loh,et al.  Effects of naloxone on d-amphetamine- and apomorphine-induced behavior , 1982, Neuropharmacology.

[28]  L. Brady,et al.  Effects of intraventricular morphine and enkephalins on locomotor activity in nondependent, morphine-dependent and postdependent rats. , 1981, The Journal of pharmacology and experimental therapeutics.

[29]  E. T. Iwamoto.  Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists. , 1981, The Journal of pharmacology and experimental therapeutics.

[30]  R. Beauchamp,et al.  Potentiation of apomorphine and D-amphetamine effects by naloxone. , 1981, Life sciences.

[31]  A. Cowan,et al.  Naloxone antagonizes behavioural effects of d-amphetamine in mice and rats , 1978, Neuropharmacology.